News for Matinas BioPharma Holdings, Inc. (MTNB)

BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. ( American: MTNB) today announced the appointment of biotech industry ve

**media[540377]**

BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE:MTNB) announces that on January 6, 2025, it received a NYSE American LLC notice indicating that the Company has fallen below

Shares of DLocal Limited DLO rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter revenue results. DLocal r...

Shares of Grab Holdings Limited GRAB rose sharply in today's pre-market trading after the company posted better-than-expected results for its third quarter and ...

MTNB stock touches 52-week low at $0.5 amid sharp annual decline

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping around 500 points on Thursday. The Dow traded down 0.62% to 41,880.03 whi...

U.S. stocks traded lower midway through trading, with the Dow Jones index more than 300 points on Thursday. The Dow traded down 0.78% to 41,810.80 while the NA...

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday. The Dow traded down 0.40% to 41,972.69 while the NASDAQ fell...

Overview of Highbridge Capital Management's Recent Trade On September 30, 2024, Highbridge Capital Management LLC, a prominent New York-based hedge fund, execut

Net Loss: $5.7 million or $0.02 per share for Q2 2024, compared to $6.1 million or $0.03 per share for Q2 2023.Total Costs and Expenses: $5.8 million for Q2 20

Aug 14, 2024 / 08:30PM GMTOperator Welcome to the Matinas BioPharma second-quarter 2024 financial results conference call. (Operator instructions) As a reminder